PKI News and Press, PerkinElmer Inc. From 03/28/21

When we read the charts for Perkinelmer (NYSE: PKI) we are able to reach conclusion that are not otherwise discernable.  We can see where buy signals exist, where sell signals exist, and where risk controls should be implemented.  These are what create trading plans.  The...

This price action in Perkinelmer (NYSE: PKI) can help investors find opportunity, and manage risk.  Stock Traders Daily has demonstrated that in this article.  Review The plans for PKI below, and you will see how this works. Keep in mind, this data is current, but it is not re...

Agilent Technologies ([[A]] +0.6%) is likely to benefit from the recovery trade in the industry, argues Citi analyst Patrick Donnelly upgrading the stock to buy from neutral.The price target of $150.00 per share indicates a premium of ~22.4% to the previous close, and the stock is trading mar...

Merger activity decreased last week with four new deals announced. Coherent and Aegion receive rival bids. Athene Holding to merge with Apollo Global Management. For further details see: Merger Arbitrage Mondays - Bidding Wars And Revised Agreements

PerkinElmer (PKI) is a high-end supplier of lab equipment. The company's business has thrived during the coronavirus due to its testing kit. Stocks have sold off over the last few weeks, here's why it could be a buying opportunity. PerkinElmer ( PKI ) is one of the 9 stocks featu...

The next move in a stock's price is often identifiable in advance.  This Perkinelmer (NYSE: PKI) report attempts to do that, and in the process help investors learn how price acton can be revealing.  Trading plans for PKI make these observations actionable, but the data on thi...

After experiencing a powerful rally since last March’s market correction, growth stocks have started to see a sell-off lately. However, because pandemic-driven trends are expected to continue in the foreseeable future, some growth stocks are still worth buying to benefit from their fut...

PerkinElmer, Inc. , (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to ...

Company expands SARS-CoV-2 assay portfolio with RT-PCR and next generation sequencing solutions to identify mutations associated with SARS-CoV-2 variants PerkinElmer, Inc. (NYSE:PKI) today announced the launch of two Research Use Only (RUO) solutions, PKamp™ Var...

Another $1.9T is set to hit the U.S. economy, including direct stimulus checks, after the Senate passed the COVID relief bill on party lines over the weekend.Goldman Sachs' Abby Joseph Cohen tells Bloomberg it's not just a stimulus package, but a "relief package that's getting us out of a hol...